InterMune Reports Successful Trial for Lung Disease Drug The company said it would apply for United States regulatory approval of pirfenidone to treat idiopathic pulmonary fibrosis, a scarring of the lungs. ANDREW POLLACK February 26, 2014 at 5:00AM http://nyti.ms/1fo3tMH The New York Times Business Day Drugs (Pharmaceuticals)

By ANDREW POLLACK from NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1fo3tMH

via IFTTT